Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ADA 2019: Real-World Study Shows Abbott's FreeStyle Libre CGM Reduced HbA1c Levels In Type 2 Diabetics

Jun 10 2019

• By Marion Webb

Medical doctor pressing 'Diabetes' button on virtual touch screen on blue technology background - Image — • Source: shutterstock.com

Related Content

Glooko And T1D Exchange Enter Partnership To Leverage Device Data From Type 1 Diabetics

Jun 04 2019

Glooko Inks Partnership Deal With Companion Medical To Integrate Insulin Pen Data

Jun 05 2019

Continuous Glucose Monitor From Senseonics Earns FDA Approval For ‘Non-Adjunctive’ Claim

Jun 10 2019

Related Companies

Abbott

Additional Topics

Clinical Trials Approvals Research & Development Diabetic Care Medical Device

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window